Commission Implementing Regulation (EU) 2021/566 of 30 March 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis et al (see notes for full title)
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
292/2021 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2021/566 of 30 March 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis et al (see notes for full title)
Durchführungsverordnung (EU) 2021/566 der Kommission vom 30. März 2021 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für die Wirkstoffe Abamectin, Bacillus subtilis (Cohn 1872) [....]
History
30.10.2021
Adopted JCD confirmed entry into force date
30.10.2021
Compliance date in the EEA
29.10.2021
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
21.07.2021
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
30.03.2021
Adoption date in the EU
27.04.2021
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.